Clinical Trial

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 23, 2026 (before its estimated July 24, 2026 completion). Its status may not reflect the trial's current state.
Summary
The main objective of this trial is to evaluate the pharmacokinetics of two evolocumab drug products in healthy participants.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-24
Trial Details
NCT Number NCT07422285
Lead Sponsor Amgen
Conditions Healthy Participants, Pharmacokinetics
Enrollment 405 participants
Start Date 2026-01-16
Primary Completion 2026-07-24 (estimated)
Study Completion 2026-07-24 (estimated)
Updated on ClinicalTrials.gov 2026-06-23